Metabolic Regulation of T Cells in the Tumor Microenvironment by Nutrient Availability and Diet
Overview
Affiliations
Recent advances in immunotherapies such as immune checkpoint blockade (ICB) and chimeric antigen receptor T cells (CAR-T) for the treatment of cancer have generated excitement over their ability to yield durable, and potentially curative, responses in a multitude of cancers. These findings have established that the immune system is capable of eliminating tumors and led us to a better, albeit still incomplete, understanding of the mechanisms by which tumors interact with and evade destruction by the immune system. Given the central role of T cells in immunotherapy, elucidating the cell intrinsic and extrinsic factors that govern T cell function in tumors will facilitate the development of immunotherapies that establish durable responses in a greater number of patients. One such factor is metabolism, a set of fundamental cellular processes that not only sustains cell survival and proliferation, but also serves as a means for cells to interpret their local environment. Nutrient sensing is critical for T cells that must infiltrate into a metabolically challenging tumor microenvironment and expand under these harsh conditions to eliminate cancerous cells. Here we introduce T cell exhaustion with respect to cellular metabolism, followed by a discussion of nutrient availability at the tumor and organismal level in relation to T cell metabolism and function to provide rationale for the study and targeting of metabolism in anti-tumor immune responses.
Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance.
Suri C, Pande B, Suhasini Sahithi L, Swarnkar S, Khelkar T, Verma H Cancer Drug Resist. 2025; 8:7.
PMID: 40051496 PMC: 11883236. DOI: 10.20517/cdr.2024.164.
Dysfunction of exhausted T cells is enforced by MCT11-mediated lactate metabolism.
Peralta R, Xie B, Lontos K, Nieves-Rosado H, Spahr K, Joshi S Nat Immunol. 2024; 25(12):2297-2307.
PMID: 39516648 PMC: 11588660. DOI: 10.1038/s41590-024-01999-3.
Qiu D, He Y, Feng Y, Lin M, Lin Z, Zhang Z Front Oncol. 2024; 14:1424824.
PMID: 39091919 PMC: 11291205. DOI: 10.3389/fonc.2024.1424824.
Inosine induces stemness features in CAR-T cells and enhances potency.
Klysz D, Fowler C, Malipatlolla M, Stuani L, Freitas K, Chen Y Cancer Cell. 2024; 42(2):266-282.e8.
PMID: 38278150 PMC: 10923096. DOI: 10.1016/j.ccell.2024.01.002.
CD8 T cells in the cancer-immunity cycle.
Giles J, Globig A, Kaech S, Wherry E Immunity. 2023; 56(10):2231-2253.
PMID: 37820583 PMC: 11237652. DOI: 10.1016/j.immuni.2023.09.005.